| GE Healthcare AG - Vizamyl 150MBq/ml, Injektionslösung |
| 66110 | | 01 | | Vizamyl 150MBq/ml | | Injektionslösung | | V09AX04 | | Flutemetamol (18f) | | 12.04.2017 | | |
|
| Composition |
| flutemetamolum(18-F) 150 MBq, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dodecahydricus, natrii chloridum, ethanolum anhydricum 0.07 ml, polysorbatum 80, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium 4.1 mg. |
| Packungsbestandteile |
| Solution injectable | | | | | | Principe actif | Concentr. |
|---|
| Flutemetamolum(18-f) | 150 MBq/ml |
| | | | Agents auxilliaires | Concentr. |
|---|
| Disodium Phosphate Dodecahydrate | | | Ethanol Anhydrate | 0.07 ml | | Sodium Chlorure | | | Sodium Dihydrogenophosphate Dihydrate | | | Polysorbatum 80 | |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 10 ml | DDP | DDP | A | | Oui | | 002 | 15 ml | DDP | DDP | A | | Oui |
|
